Adani Enterp. 2451.15↑22.00(0.91%)
Adani Ports 734.95↓-1.45(-0.20%)
Apollo Hospitals 4926.70↓0.05(0.00%)
Asian Paints 3180.55↓-31.70(-0.99%)
Axis Bank 974.75↑12.65(1.31%)
B P C L 359.45↓-1.65(-0.46%)
Bajaj Auto 4743.40↓-57.25(-1.19%)
Bajaj Finance 7037.15↑27.05(0.39%)
Bajaj Finserv 1466.50↓-0.90(-0.06%)
Bharti Airtel 833.50↓-2.50(-0.30%)
Britannia Inds. 4878.75↑3.70(0.08%)
Cipla 969.25↑3.85(0.40%)
Coal India 227.65↓-0.45(-0.20%)
Divi's Lab. 3428.75↓-70.95(-2.03%)
Dr Reddy's Labs 4666.80↑17.40(0.37%)
Eicher Motors 3581.30↓-76.10(-2.08%)
Grasim Inds 1715.75↑3.80(0.22%)
H D F C 2652.90↓-0.90(-0.03%)
HCL Technologies 1109.75↓-17.00(-1.51%)
HDFC Bank 1610.60↑1.90(0.12%)
HDFC Life Insur. 581.70↓-12.20(-2.05%)
Hero Motocorp 2899.30↓-65.50(-2.21%)
Hind. Unilever 2636.20↓-43.70(-1.63%)
Hindalco Inds. 415.05↓-3.20(-0.77%)
ICICI Bank 938.05↑0.15(0.02%)
IndusInd Bank 1331.05↑27.20(2.09%)
Infosys 1265.95↓-16.85(-1.31%)
ITC 438.45↓-4.45(-1.00%)
JSW Steel 748.50↓-0.30(-0.04%)
Kotak Mah. Bank 1872.00↓-14.50(-0.77%)
Larsen & Toubro 2363.00↑22.70(0.97%)
M & M 1370.65↓-10.40(-0.75%)
Maruti Suzuki 9627.80↓-30.80(-0.32%)
Nestle India 22073.45↓-75.45(-0.34%)
NTPC 182.80↑0.75(0.41%)
O N G C 154.25↓-1.85(-1.19%)
Power Grid Corpn 244.90↑3.25(1.34%)
Reliance Industr 2481.95↓-17.70(-0.71%)
SBI Life Insuran 1232.40↓-6.50(-0.52%)
St Bk of India 578.70↓-9.80(-1.67%)
Sun Pharma.Inds. 983.95↓-3.05(-0.31%)
Tata Consumer 801.00↓-6.10(-0.76%)
Tata Motors 562.30↑2.60(0.46%)
Tata Steel 108.90↓-2.25(-2.02%)
TCS 3209.30↓-27.15(-0.84%)
Tech Mahindra 1063.05↓-8.25(-0.77%)
Titan Company 2876.25↓-0.75(-0.03%)
UltraTech Cem. 8153.25↑53.10(0.66%)
UPL 680.25↓-9.80(-1.42%)
Wipro 397.30↓-2.25(-0.56%)

US plans Covid-19 booster shots at six months instead of eight: Report

Pfizer and BioNTech have already started the application process for the approval of its booster shot in people 16 and older

Premium

Approval of boosters for three Covid-19 shots being administered in the United States include those manufactured by Pfizer and partner BioNTech SE.

1 min read Last Updated : Aug 27 2021 | 2:37 AM IST

US health regulators could approve a third Covid-19 shot for adults beginning at least six months after full vaccination, instead of the previously announced eight-month gap, the Wall Street Journal reported on Wednesday.

Approval of boosters for three Covid-19 shots being administered in the United States include those manufactured by Pfizer and partner BioNTech SE. Moderna and Johnson & Johnson are expected in mid-September, the report said, citing a person familiar with the plans.

Pfizer and BioNTech have already started the application process for the approval of its booster shot in people 16 and older, saying it spurs a more than three-fold increase in antibodies against the coronavirus.

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)